Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab.
作者信息
Lamothe Pedro A, Runnstrom Martin, Smirnova Natalia, Flores Flavio C, Shepherd Aaron, Park Jiwon, Lee F Eun-Hyung
机构信息
Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Ga.
Morehouse School of Medicine, Atlanta, Ga.
出版信息
J Allergy Clin Immunol Pract. 2023 May;11(5):1556-1558.e2. doi: 10.1016/j.jaip.2022.12.049. Epub 2023 Jan 25.
Abstract
摘要
相似文献
1
Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab.同卵双胞胎中的变应性支气管肺曲霉病：度普利尤单抗的疗效
J Allergy Clin Immunol Pract. 2023 May;11(5):1556-1558.e2. doi: 10.1016/j.jaip.2022.12.049. Epub 2023 Jan 25.
2
A case of allergic bronchopulmonary aspergillosis in a child: Response to dupilumab.一名儿童过敏性支气管肺曲霉病病例：对度普利尤单抗的反应。
J Allergy Clin Immunol Pract. 2024 Aug;12(8):2178-2179. doi: 10.1016/j.jaip.2024.04.018. Epub 2024 Apr 18.
3
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.针对囊性纤维化患者的过敏性支气管肺曲霉病的抗IgE治疗。
Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD010288. doi: 10.1002/14651858.CD010288.pub4.
4
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.抗IgE疗法用于治疗囊性纤维化患者的过敏性支气管肺曲霉病。
Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.
5
Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.抗IgE疗法用于治疗囊性纤维化患者的过敏性支气管肺曲霉病。
Cochrane Database Syst Rev. 2013 Sep 17(9):CD010288. doi: 10.1002/14651858.CD010288.pub2.
6
Allergic bronchopulmonary aspergillosis and omalizumab.变应性支气管肺曲霉病与奥马珠单抗
Allergy. 2011 Sep;66(9):1254-6. doi: 10.1111/j.1398-9995.2011.02599.x. Epub 2011 Apr 26.
7
Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.在对奥马珠单抗无反应的患者中，使用贝那利珠单抗成功治疗变应性支气管肺曲霉病。
J Investig Allergol Clin Immunol. 2020;30(5):378-379. doi: 10.18176/jiaci.0564. Epub 2020 May 6.
8
Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.奥马珠单抗和美泊利单抗联合治疗难治性变应性支气管肺曲霉病
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1137-1139. doi: 10.1016/j.jaip.2017.01.013. Epub 2017 Mar 6.
9
Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.接受奥马珠单抗治疗的变应性支气管肺曲霉病患者总IgE意外下降
J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):111-3. doi: 10.1016/j.jaip.2013.08.014. Epub 2013 Oct 19.
10
Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis.度普利尤单抗及生物标志物对初治系统性皮质类固醇的变应性支气管肺曲霉病的疗效
Allergol Int. 2021 Jan;70(1):145-147. doi: 10.1016/j.alit.2020.08.006. Epub 2020 Sep 8.
引用本文的文献
1
Treatment of allergic bronchopulmonary aspergillosis with biologics.使用生物制剂治疗变应性支气管肺曲霉病。
Chin Med J Pulm Crit Care Med. 2025 Jan 10;3(1):6-11. doi: 10.1016/j.pccm.2024.11.005. eCollection 2025 Mar.
2
Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis.抗白细胞介素-4受体α（Anti-IL-4Ra）疗法在治疗变应性支气管肺曲霉病方面优于其他生物制剂类别。
J Allergy Clin Immunol Glob. 2024 Nov 12;4(1):100369. doi: 10.1016/j.jacig.2024.100369. eCollection 2025 Feb.
3
Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?变应性支气管肺曲霉病/真菌病：是一种变应性疾病还是嗜酸性粒细胞疾病？
Intern Med. 2025 Feb 15;64(4):493-501. doi: 10.2169/internalmedicine.4386-24. Epub 2024 Sep 4.
4
Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.变应性支气管肺曲霉病患者使用生物制剂的疗效：系统评价和荟萃分析。
Lung. 2024 Aug;202(4):367-383. doi: 10.1007/s00408-024-00717-y. Epub 2024 Jun 19.
5
The origins and longevity of IgE responses as indicated by serological and cellular studies in mice and humans.通过在小鼠和人类中进行血清学和细胞研究表明 IgE 反应的起源和持久性。
Allergy. 2023 Dec;78(12):3103-3117. doi: 10.1111/all.15799. Epub 2023 Jul 7.
本文引用的文献
1
Biologic Therapies for Severe Asthma.重度哮喘的生物疗法
N Engl J Med. 2022 Jan 13;386(2):157-171. doi: 10.1056/NEJMra2032506.
2
Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab.使用度普利尤单抗治疗的ABPA和哮喘患者的病情加重频率和泼尼松剂量降低。
Clin Transl Allergy. 2021 Dec;11(10):e12081. doi: 10.1002/clt2.12081.
3
Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of Chronic Eosinophilic Pneumonia and Allergic Bronchopulmonary Aspergillosis - Case series, Almoosa specialist hospital.美泊利单抗和度普利尤单抗替代全身糖皮质激素治疗慢性嗜酸性粒细胞性肺炎和变应性支气管肺曲霉病——病例系列，阿尔穆萨专科医院
Respir Med Case Rep. 2021 Oct 1;34:101520. doi: 10.1016/j.rmcr.2021.101520. eCollection 2021.
4
Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab.成功使用度普利尤单抗治疗美泊利珠单抗和泼尼松龙耐药性变应性支气管肺曲霉病。
Intern Med. 2021 Sep 1;60(17):2839-2842. doi: 10.2169/internalmedicine.6679-20. Epub 2021 Mar 1.
5
Adult-onset eosinophilic airway diseases.成人起病的嗜酸性气道疾病。
Allergy. 2020 Dec;75(12):3087-3099. doi: 10.1111/all.14620. Epub 2020 Oct 23.
6
New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation.变应性支气管肺曲霉病/真菌病的新临床诊断标准及其验证。
J Allergy Clin Immunol. 2021 Apr;147(4):1261-1268.e5. doi: 10.1016/j.jaci.2020.08.029. Epub 2020 Sep 10.
7
Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series.度普利尤单抗治疗变应性支气管肺曲霉病：病例系列
J Allergy Clin Immunol Pract. 2020 Feb;8(2):742-743. doi: 10.1016/j.jaip.2019.11.031. Epub 2019 Dec 4.
8
Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC.抑制气道上皮中白细胞介素-13诱导的骨膜蛋白可减弱黏蛋白5AC的细胞蛋白表达。
Respirology. 2017 Jan;22(1):93-100. doi: 10.1111/resp.12873. Epub 2016 Aug 24.
9
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria.变应性支气管肺曲霉病：文献回顾与新的诊断和分类标准的建议。
Clin Exp Allergy. 2013 Aug;43(8):850-73. doi: 10.1111/cea.12141.
Zotero 插件